Study to assess bone height changes around dental implants by using Concentrated Growth Factor at the implant placement site

Not yet recruiting

• Conditions: Disorder of gingiva and edentulousalveolar ridge, unspecified,

• Registration Number: CTRI/2025/05/087893
• Lead Sponsor: Allu Priyanka

Brief Summary

This is a randomized control trail .Patient selection will be done after the assessment of eligibility criteria. In Phase I therapy oral prophylaxis and surgical stunt fabrication will be done. And patient will be recalled after 1 week for surgical procedure.The procedure will be performed under local anesthesia using 2% lignocaine containing adrenaline 1:80,000.A midcrestal incision will be given in both cases. A mucoperiosteal flap will be elevated and osteotomy site will be prepared.In Group 1 patients, implants will be placed without CGF and in Group 2 implants will be placed with CGF. After placement, stability will be checked with RFA at baseline.Cover screw will be given following the

implant placement and flaps will be approximated and sutured. Patient will be recalled after 3 months and 6 months for evaluation of parameters like RFA and IOPA.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2025-09-04
• Study Start: 2025-10-06

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 26

Inclusion Criteria

• Patients with an age group of 20-60 years of either gender.
• Patients in need of implant supported tooth replacement.
• Presence of adequate keratinized mucosa (minimum 1 mm) in the edentulous site.
• Apparently healthy patients.
• Patients with bone density classified as D2 and D3 type of bone using CBCT.

Exclusion Criteria

• 1.Any forms of tobacco users.
• 2.Pregnant and lactating women.
• 3.Patients taking any medication which effect healing and bone metabolism.
• 4.Patients with a history of immune disease, uncontrolled diabetes, blood disorders, ongoing chemotherapy, radiation treatment to head and neck, alcohol or drug abuse, psychological instability.
• 5.Patients with parafunctional habits.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To evaluate the implant stability around implants with Concentrated growth factor.	Baseline and 3 months

Secondary Outcome Measures

Name	Time	Method
To evaluate the crestal bone level around implants with Concentrated growth factor.	Baseline and 3 months and 6 months

Trial Locations

Locations (1)

Sibar Institute of Dental Sciences; 🇮🇳 Guntur, ANDHRA PRADESH, India

Sibar Institute of Dental Sciences

🇮🇳Guntur, ANDHRA PRADESH, India

Dr Allu Priyanka

Principal investigator

6303901830

parimalaallu08@gmail.com